What is Nidan Laboratories And Healthcare Ltd (NIDAN) share price return in the past 10 years?

Data is not available for this company

What is the share price of Nidan Laboratories And Healthcare Ltd (NIDAN)?

Company share prices are keep on changing according to the market conditions. The current trading price of Nidan Laboratories And Healthcare Ltd (NIDAN) on 01-Jan-1970 05:30:00 at 05:30 is .

What is the P/E ratio of Nidan Laboratories And Healthcare?

The latest standalone P/E ratio of Nidan Laboratories And Healthcare as of 01-Jan-1970 is 12.55.

What is the P/B ratio of Nidan Laboratories And Healthcare Ltd (NIDAN)?

The latest standalone P/B ratio of Nidan Laboratories And Healthcare Ltd (NIDAN) as of 01-Jan-1970 is 0.28.

What is the 52-week high and low of Nidan Laboratories And Healthcare Ltd (NIDAN)?

The 52-week high of Nidan Laboratories And Healthcare Ltd (NIDAN) is Rs. 0.00 and the 52-week low is Rs. 0.00.

What is the TTM revenue of Nidan Laboratories And Healthcare Ltd (NIDAN)?

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Nidan Laboratories And Healthcare is Rs. 25.54 (Cr.).

Nidan Laboratories And Healthcare Ltd (NIDAN) Share Analysis – Quality, Pipeline & Valuation Zone & DeciZen Rating

Name: Nidan Laboratories And Healthcare Ltd (NIDAN)
Brand: Nidan Laboratories And Healthcare

Nidan Laboratories And Healthcare Ltd (NIDAN)

Key Metrics

Valuation Multiples

Market Cap

₹19 Cr.

Current Price

₹0

52-Week Low / High

₹0 / 0

TTM EPS

₹1.1

TTM Sales

₹25.5 Cr.

Book Value per Share

₹49.1

P/E Ratio

12.55

Lower than its 5-year historical median

Industry PE

91.4

Price to Book (P/B)

0.28

Lower than its 5-year historical median

Price to Sales (P/S)

0.74

Lower than its 5-year historical median

EV/EBITDA

4.20

Lower than its 5-year historical median

Dividend Yield

NAN%

Profitability Efficiency

Return on Equity (ROE)

2.94%

Underperforms industry median

Return on Capital Employed (ROCE)

6.21%

Underperforms industry median

Return on Assets (ROA)

2.41%

Operating Profit Margin

20.6%

Net Profit Margin

8.06%

Gross Profit Margin

21.1%

Growth Momentum
1-yr vs 3-yr growth

Sales Growth (1 Year)

Improving versus 3-year growth rate

1.45%

Operating Profit Growth (1 Year)

Slowing versus 3-year growth rate

-21.43%

Net Profit Growth (1 Year)

Asset Quality

Promoter Holding

57.04%

Pledged shares (%) of Promoter's holding (%)

0.00%

Reserves

₹54 Cr.

Equity

₹13.9 Cr.

Face Value

₹10

All Time Low / High

- / -

Nidan Laboratories And Healthcare stock performance

Key Ratios

Check Before You Invest

M-Cap below 100cr DeciZen not available

Q.1 Is Nidan Laboratories And Healthcare Ltd a good quality company?

Nidan Laboratories And Healthcare Ltd is a quality company, based on a multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

We have analysed the performance of the company on the following:

How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.

How does Nidan Laboratories And Healthcare Ltd performance compare with that of its Peers?

Q.1 Revenue growth of Nidan Laboratories And Healthcare Ltd vs industry peers?

Nidan Laboratories And Healthcare Ltd revenue CAGR is 2.76%, compared to the industry median CAGR of 1.38%, indicating faster growth and gaining its market share.

Q.1 Promoter shareholding and pledge status of Nidan Laboratories And Healthcare Ltd?

Promoters hold 57.04% of the Nidan Laboratories And Healthcare Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Q.1 Stock return of Nidan Laboratories And Healthcare Ltd over the last decade?

Over the last 3 year(s), the stock has delivered a CAGR of -30.37% based on the current price.

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
ROCE % ⓘ	11.7%	10.2%	14%	10.5%	8.5%	-0.2%	6.2%	-
Value Creation Index ⓘ	-0.2	-0.3	-0	-0.3	-0.4	-1.0	-0.6	-
Growth Parameters ⓘ
Sales ⓘ	20.1	21.4	20.4	29.7	24.3	24.2	24.5	26
Sales YoY Gr.	-	6.7%	-4.8%	45.5%	-18.2%	-0.4%	1.5%	-
Adj EPS ⓘ	0.2	0.7	2.3	1.8	2.4	1	1.4	1.1
YoY Gr.	-	213%	223.6%	-24%	36.2%	-60.6%	48.4%	-
BVPS (₹) ⓘ	10.4	11.1	13.5	47.4	50	47.6	49.1	49.1
Adj Net Profit ⓘ	0.2	0.7	2.3	2.5	3.4	1.3	2	2
Cash Flow from Ops. ⓘ	9	4.6	4.4	7.8	11	5.5	2.3	-
Debt/CF from Ops. ⓘ	3.6	7.4	8.8	2.5	1	2.3	4.9	-

CAGR ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	NA	2.8%	-6.1%	1.5%
Adj EPS ⓘ	NA	14.4%	-7.3%	48.4%
BVPSⓘ	NA	34.5%	1.1%	3%
Share Price	-	-	-33.8%	-33.7%

Key Financial Parameters ⓘ

	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
Return on Equity % ⓘ	2.2	6.7	18.9	6.2	5	2	2.9	2.2
Op. Profit Mgn % ⓘ	39.1	35.7	43.6	31.7	28	26.7	20.6	NAN
Net Profit Mgn % ⓘ	1.1	3.3	11.3	8.3	13.8	5.5	8	5.9
Debt to Equity ⓘ	3.1	3.1	2.9	0.3	0.2	0.2	0.2	-
Working Cap Days ⓘ	0	269	383	501	825	868	779	0
Cash Conv. Cycle ⓘ	0	89	78	39	73	43	0	0

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Sales	20.06	21.41	20.38	29.66	24.27	24.18	24.53
Operating Expenses ⓘ +	12.22	13.77	11.49	20.25	17.46	17.73	19.47
Manufacturing Costs	2.13	2.42	1.16	5.77	4.92	6.04	8.24
Material Costs	1.72	2.55	2.21	3.09	1.09	1.01	0.78
Employee Cost	2.35	2.77	2.85	3.59	4.88	4.46	4.36
Other Costs ⓘ	6.02	6.04	5.27	7.80	6.57	6.22	6.09
Operating Profit ⓘ	7.84	7.64	8.89	9.41	6.80	6.44	5.06
Operating Profit Margin (%)	39.1%	35.7%	43.6%	31.7%	28.0%	26.7%	20.6%
Other Income ⓘ +	0.37	0.01	1.06	0.40	3.33	2.75	2.25
Exceptional Items ⓘ	0	0	0	0	0	-6.51	0
Interest ⓘ	4.75	3.74	3.46	2.66	2.22	2.18	2.14
Depreciation ⓘ	3.24	3.19	3.18	2.63	3.10	2.87	2.41
Profit Before Tax ⓘ	0.22	0.71	3.30	4.52	4.81	-2.37	2.76
Tax ⓘ	0	0	1	1.86	1.27	0.86	0.78
Profit After Tax	0.22	0.71	2.30	2.66	3.54	-3.23	1.98
PAT Margin (%)	1.1%	3.3%	11.3%	9.0%	14.6%	-13.4%	8.1%
Adjusted EPS (₹)	0.2	0.7	2.3	1.9	2.6	-2.3	1.4
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%

Valuation of Nidan Labs. & Health - Standalone

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Equity and Liabilities
Shareholders Fund +	10.31	11.03	13.33	65.90	69.44	66.21	68.18
Share Capital ⓘ	9.90	9.90	9.90	13.90	13.90	13.90	13.90
Reserves ⓘ	0.41	1.13	3.43	52	55.54	52.31	54.28
Debt +	32.17	34.35	22.91	18.13	9.66	11.66	10.83
Long Term Debt	32.17	34.35	14.16	9.42	4.77	4.29	3.90
Short Term Debt	0	0	8.76	8.71	4.89	7.37	6.94
Minority Interest	0	0	0	0	0	0	0
Trade Payables	0.55	-0.18	1.29	1.15	0.21	0.73	0.96
Others Liabilities ⓘ	-0.22	-0.24	15.96	2.85	4.61	3.14	2.20
Total Liabilities ⓘ	42.81	44.96	53.49	88.03	83.92	81.73	82.17
Fixed Assets
Net Fixed Assets ⓘ +	23.28	20.10	19.92	20.46	21.39	17.95	16.33
Gross Block	55.36	55.37	58.36	59.74	60.65	57.67	58.44
Accumulated Depreciation	32.08	35.26	38.45	39.28	39.26	39.72	42.10
CWIP ⓘ	0	0	0.23	3.81	0	0.04	0.15
Investments ⓘ	0.53	0.53	0.27	0	0	0	20
Inventories	0.08	0.09	0.11	0.22	0.37	0.30	0.55
Trade Receivables	5.61	5.43	5.43	5.36	6.03	0.52	1.27
Cash Equivalents	4.34	7.39	7.30	8.10	8.42	2.85	1.90
Others Assets ⓘ	8.97	11.42	20.24	50.07	47.72	60.07	41.97
Total Assets ⓘ	42.81	44.96	53.49	88.03	83.92	81.73	82.17

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Cash Flow From Operating Activity ⓘ +	8.95	4.62	4.35	7.83	10.97	5.52	2.28
PBT ⓘ	0.22	0.71	3.30	4.52	4.81	-2.37	2.76
Adjustment ⓘ	7.99	6.93	6.55	4.54	2.04	9.19	2.23
Changes in Working Capital ⓘ	0.74	-3.03	-5.51	-0.07	4.15	1.5	-1.11
Tax Paid ⓘ	0	0	0	-1.16	-0.03	-2.80	-1.60
Cash Flow From Investing Activity ⓘ +	1	-0.01	-3.22	-35.74	-0.29	-10.60	-0.22
Capex	1	-0.01	-3.22	-6.48	0.05	-0.64	-0.87
Net Investments	0	0	0	0	0	0	-20
Others ⓘ	0	0	0	-29.26	-0.34	-9.96	20.65
Cash Flow From Financing Activity ⓘ +	-5.81	-1.56	-1.22	28.72	-10.37	-0.49	-3.01
Net Proceeds from Shares ⓘ	0	0	0	49.91	0	0	0
Net Proceeds from Borrowing ⓘ	-1.06	2.18	2.15	-18.75	-8.36	1.49	-1.20
Interest Paid ⓘ	-4.75	-3.74	-3.36	-2.44	-2	-1.97	-1.81
Dividend Paid ⓘ	0	0	0	0	0	0	0
Others ⓘ	0	0	0	-0	0	-0	-0
Net Cash Flow ⓘ	4.14	3.05	-0.10	0.80	0.32	-5.57	-0.95

Financial Ratio

PARTICULARS	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Ratios
ROE (%)	2.17	6.7	18.9	6.72	5.23	-4.77	2.94
ROCE (%)	11.71	10.15	13.98	10.52	8.5	-0.24	6.21
Asset Turnover Ratio	0.47	0.49	0.41	0.42	0.28	0.29	0.3
PAT to CFO Conversion(x)	40.68	6.51	1.89	2.94	3.1	N/A	1.15
Working Capital Days
Receivable Days	102.10	94.20	97.30	66.40	85.70	49.50	13.30
Inventory Days	1.40	1.40	1.70	2	4.40	5	6.30
Payable Days	116.20	26.20	91.40	144	227	168.50	397.80

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Nidan Laboratories And Healthcare Ltd FAQs

The current trading price of Nidan Labs. & Health on 01-Jan-1970 05:30 is ₹0.00.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Nidan Labs. & Health stood at ₹18.90 Cr

The latest P/E ratio of Nidan Labs. & Health as of 31-Dec-1969 is 12.55.

The latest P/B ratio of Nidan Labs. & Health as of 31-Dec-1969 is 0.28.

The 52-week high of Nidan Labs. & Health is ₹0.00 and the 52-week low is ₹0.00.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Nidan Labs. & Health is ₹25.54 ( Cr.) .

Past 10 year's financial track record analysis by Moneyworks4me indicates that Nidan Laboratories And Healthcare Ltd is a average quality company.

The key valuation ratios of Nidan Laboratories And Healthcare Ltd's currently when compared to its past seem to suggest it is in the Undervalued zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Nidan Laboratories And Healthcare Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

About Nidan Laboratories And Healthcare Ltd

Nidan Laboratories and Healthcare was originally incorporated as Abhi Diagnostic Imagings Private Limited on December 5, 2000 under the Companies Act, 1956 vide certificate of incorporation issued by the Registrar of Companies, Maharashtra. Subsequently, the name of the company was changed from “Abhi Diagnostic Imagings Private Limited” to “Nidan Laboratoris And Healthcare Private Limited” under the Companies Act, 2013 pursuant to a special resolution passed by its shareholders at the EGM held on February 26, 2021 and had obtained fresh certificate of incorporation dated March 24, 2021 issued by the Registrar of Companies, Maharashtra. Subsequently, the company was converted into a public limited company and the name of the company was changed to ‘Nidan Laboratories And Healthcare Limited’ and a fresh certificate of incorporation consequent upon conversion to public limited company was issued by the Registrar of Companies, Mumbai, Maharashtra, on May 24, 2021.

The company was established as a proprietary Firm in 1994 by its Promoter- Dr. Nitin Vithalrao Throve in the Northern District of Mumbai where diagnostic services was provided under one roof at reliable and affordable price. The business was carried out under sole proprietorship, which was later taken over by the company in 2000. From the year 2000, he expanded the diagnostic’s business by setting up various centre’s within the Northern District of Mumbai and Pune and Southern District of Pune.

Business area of the company

The company offers diagnostic services including radiology, neurology, cardiology, dental as well as pathology services. The company provides pathology tests ranging from basic biochemistry and clinical pathology to cytogenetic and high-end molecular diagnostic tests, and radiology tests ranging from basic echocardiograms, X-Rays, and ultrasounds to advanced radiology tests including computerized tomography (CT) scans, magnetic resonance imaging (MRI) scans. The company also offers a broad spectrum of customized health and wellness packages to its customers and offers value-added services to its customers such as a home collection of specimens, house calls, and various delivery or access modes for test reports.

Nidan Laboratories And Healthcare Ltd (NIDAN)

Nidan Laboratories And Healthcare Ltd (NIDAN)

Nidan Laboratories And Healthcare stock performance

Check Before You Invest

M-Cap below 100cr DeciZen not available

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of Nidan Labs. & Health - Standalone

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Nidan Laboratories And Healthcare Ltd FAQs

About Nidan Laboratories And Healthcare Ltd

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Nidan Laboratories And Healthcare Ltd (NIDAN)

Nidan Laboratories And Healthcare Ltd (NIDAN)

Nidan Laboratories And Healthcare stock performance

Check Before You Invest

M-Cap below 100cr DeciZen not available

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of Nidan Labs. & Health - Standalone

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Nidan Laboratories And Healthcare Ltd FAQs

What is the share price of Nidan Labs. & Health?

What is the market cap of Nidan Labs. & Health?

What is the P/E ratio of Nidan Labs. & Health?

What is the P/B ratio of Nidan Labs. & Health?

What is the 52-week high and low of Nidan Labs. & Health?

What is the TTM revenue of Nidan Labs. & Health?

Is Nidan Laboratories And Healthcare Ltd a good quality company?

Is Nidan Laboratories And Healthcare Ltd undervalued or overvalued?

Is Nidan Laboratories And Healthcare Ltd a good buy now?

About Nidan Laboratories And Healthcare Ltd

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.